Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Monoclonal antibody administration. Current clinical pharmacokinetic status and future trends.

× No keyword cloud information.

19 in total

Review 1. Antibody-directed enzyme/prodrug therapy (ADEPT).

Authors: K D Bagshawe
Journal: Biochem Soc Trans Date: 1990-10 Impact factor: 5.407

2. Complete tumor ablation with iodine 131-radiolabeled disialoganglioside GD2-specific monoclonal antibody against human neuroblastoma xenografted in nude mice.

Authors: N K Cheung; B Landmeier; J Neely; A D Nelson; C Abramowsky; S Ellery; R B Adams; F Miraldi
Journal: J Natl Cancer Inst Date: 1986-09 Impact factor: 13.506

3. A pilot study of 131I monoclonal antibodies in the therapy of leptomeningeal tumors.

Authors: L S Lashford; A G Davies; R B Richardson; S P Bourne; J A Bullimore; H Eckert; J T Kemshead; H B Coakham
Journal: Cancer Date: 1988-03-01 Impact factor: 6.860

4. Accurate quantification of 131I distribution by gamma camera imaging.

Authors: A J Green; S E Dewhurst; R H Begent; K D Bagshawe; S J Riggs
Journal: Eur J Nucl Med Date: 1990

5. The effect of second antibody clearance on the distribution and dosimetry of radiolabelled anti-CEA antibody in a human colonic tumor xenograft model.

Authors: R B Pedley; R Dale; J A Boden; R H Begent; P A Keep; A J Green
Journal: Int J Cancer Date: 1989-04-15 Impact factor: 7.396

10. Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model.

Authors: R B Pedley; J A Boden; R Boden; R Dale; R H Begent
Journal: Br J Cancer Date: 1993-07 Impact factor: 7.640

Monoclonal antibody administration. Current clinical pharmacokinetic status and future trends.

Review 1. Antibody-directed enzyme/prodrug therapy (ADEPT).

2. Complete tumor ablation with iodine 131-radiolabeled disialoganglioside GD2-specific monoclonal antibody against human neuroblastoma xenografted in nude mice.

3. A pilot study of 131I monoclonal antibodies in the therapy of leptomeningeal tumors.

4. Accurate quantification of 131I distribution by gamma camera imaging.

5. The effect of second antibody clearance on the distribution and dosimetry of radiolabelled anti-CEA antibody in a human colonic tumor xenograft model.

Review 6. Antibody targeted therapy in cancer: comparison of murine and clinical studies.

7. Nonuniformity of tumor dose in radioimmunotherapy.

8. In vivo tumor targeting of a recombinant single-chain antigen-binding protein.

9. Antibody distribution and dosimetry in patients receiving radiolabelled antibody therapy for colorectal cancer.

10. Comparative radioimmunotherapy using intact or F(ab')2 fragments of 131I anti-CEA antibody in a colonic xenograft model.